Antitumor activity and prolonged expression from a TRAIL-expressing adenoviral vector.
about
Oncolytic herpes simplex virus-based strategies: toward a breakthrough in glioblastoma therapyComing of Age in the Life ofNeuronally expressed stem cell factor induces neural stem cell migration to areas of brain injury.EGFR inhibitors sensitize non-small cell lung cancer cells to TRAIL-induced apoptosis.Adeno-associated virus-mediated doxycycline-regulatable TRAIL expression suppresses growth of human breast carcinoma in nude miceTherapeutic efficacy and safety of TRAIL-producing human adipose tissue-derived mesenchymal stem cells against experimental brainstem glioma.The Biology of TRAIL and the Role of TRAIL-Based Therapeutics in Infectious DiseasesTRAIL and apoptosis induction by TNF-family death receptors.Novel chemotherapeutic agents for the treatment of glioblastoma multiforme.Recent progress in immunotherapy for malignant glioma: treatment strategies and results from clinical trials.Immunomodulatory neural stem cells for brain tumour therapy.TRAIL gene therapy: from preclinical development to clinical application.TNF-related apoptosis-inducing ligand (TRAIL): a new path to anti-cancer therapies.Sitimagene ceradenovec: a gene-based drug for the treatment of operable high-grade glioma.Clinically applicable human adipose tissue-derived mesenchymal stem cells delivering therapeutic genes to brainstem gliomas.Immune surveillance in melanoma: From immune attack to melanoma escape and even counterattack.Cancer targeting Gene-Viro-Therapy of liver carcinoma by dual-regulated oncolytic adenovirus armed with TRAIL gene.Dual-targeted antitumor effects against brainstem glioma by intravenous delivery of tumor necrosis factor-related, apoptosis-inducing, ligand-engineered human mesenchymal stem cells.The antitumor activity of TRAIL and IL-24 with replicating oncolytic adenovirus in colorectal cancer.MiRNA-mediated tumor specific delivery of TRAIL reduced glioma growth.
P2860
Q26998111-E3D7D2AF-88CB-4CF5-A04B-53EA2F0AE6C4Q28389985-D2667652-D683-48A9-A675-6A62B7F402D3Q33202586-7D2DB8E4-4EC2-4574-AD10-5A7A93989AFCQ33574958-AF75E893-2E0C-408A-894C-8EE2E7E76B63Q34244279-79492A87-438F-47EB-BB4D-493311133515Q34480527-17158B26-0385-4C97-A696-E0DC1133813AQ35172090-C4207D28-C5FD-43B3-83D4-E7F30ACB1D1BQ35591708-779AD9A5-EE3C-4F4E-AD49-E4AC2B9616EEQ35594029-05BD35E4-1A49-4F6F-BBD3-5248D91D1264Q35778581-383E66F0-8693-400F-8F3C-92969B6994D6Q36708286-82A18615-7CEB-406A-936A-1F9EF366DBFCQ37307340-228EC620-076A-46D3-A7FE-E1C23D49CE74Q37440765-F4E2BC4A-7D41-4585-B0E3-DAE2CAFA105FQ37818222-FE18E4AE-35EA-4C54-A766-06ECB2792B86Q38869957-30A73123-AF11-4436-A290-A82E88C17A96Q39312652-92F17133-829B-46FF-8ADC-3EC66FF7C38FQ39575065-9B9702BF-9C33-46E0-8754-9958F713C1FEQ39811470-DE1E22CA-5660-4CEC-80E7-30A5D3903066Q40262890-8F8B3A80-2997-4AF6-B571-EB6EA02313B6Q44522644-93508889-1FE7-4D7B-B616-603A869A9CDB
P2860
Antitumor activity and prolonged expression from a TRAIL-expressing adenoviral vector.
description
2002 nî lūn-bûn
@nan
2002 թուականի Յուլիսին հրատարակուած գիտական յօդուած
@hyw
2002 թվականի հուլիսին հրատարակված գիտական հոդված
@hy
2002年の論文
@ja
2002年論文
@yue
2002年論文
@zh-hant
2002年論文
@zh-hk
2002年論文
@zh-mo
2002年論文
@zh-tw
2002年论文
@wuu
name
Antitumor activity and prolonged expression from a TRAIL-expressing adenoviral vector.
@ast
Antitumor activity and prolonged expression from a TRAIL-expressing adenoviral vector.
@en
type
label
Antitumor activity and prolonged expression from a TRAIL-expressing adenoviral vector.
@ast
Antitumor activity and prolonged expression from a TRAIL-expressing adenoviral vector.
@en
prefLabel
Antitumor activity and prolonged expression from a TRAIL-expressing adenoviral vector.
@ast
Antitumor activity and prolonged expression from a TRAIL-expressing adenoviral vector.
@en
P2093
P2860
P356
P1433
P1476
Antitumor activity and prolonged expression from a TRAIL-expressing adenoviral vector.
@en
P2093
Howard A Fine
Jeongwu Lee
Monika Hampl
Paul Albert
P2860
P304
P356
10.1038/SJ.NEO.7900245
P577
2002-07-01T00:00:00Z